Gene: FUT4
Official Full Name: fucosyltransferase 4provided by HGNC
Gene Summary: The product of this gene transfers fucose to N-acetyllactosamine polysaccharides to generate fucosylated carbohydrate structures. It catalyzes the synthesis of the non-sialylated antigen, Lewis x (CD15). [provided by RefSeq, Jan 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37789 | FUT4 Knockout cell line (HeLa) | Human | FUT4 | 1:3~1:6 | Negative | Online Inquiry |
KO37790 | FUT4 Knockout cell line (HCT 116) | Human | FUT4 | 1:2~1:4 | Negative | Online Inquiry |
KO37791 | FUT4 Knockout cell line (HEK293) | Human | FUT4 | 1:3~1:6 | Negative | Online Inquiry |
KO37792 | FUT4 Knockout cell line (A549) | Human | FUT4 | 1:3~1:4 | Negative | Online Inquiry |
FUT4 Gene Knockout Cell Lines are genetically engineered cell lines in which the FUT4 gene, responsible for encoding the enzyme fucosyltransferase 4, has been selectively disrupted. This product serves as a critical tool for researchers aiming to investigate the biological processes mediated by fucosylation, a post-translational modification predominantly influencing cell-cell interactions, signaling pathways, and immune responses.
The key function of these knockout cell lines lies in their ability to facilitate the study of the absence of fucosylation, allowing researchers to analyze the consequences of FUT4 gene disruption in various cellular contexts. By eliminating the expression of haltingly crucial fucosyltransferase, these models enable scientists to explore the functional roles of fucosylated glycoproteins, aiding our understanding of diseases such as cancer and metabolic disorders where abnormal fucosylation patterns are often observed.
In scientific research and clinical applications, FUT4 Gene Knockout Cell Lines are vital for dissecting the mechanisms underlying immune response modulation and tumor progression. They offer a unique advantage by providing a more physiologically relevant system for drug testing and therapeutic interventions. Compared to traditional cell lines that express FUT4, these knockout variants present a valuable alternative for high-throughput screening and validation of fucosylation-targeted therapies, enabling more precise and targeted investigation of glycosylation-related pathways.
Researchers and clinicians will find immense value in these cell lines, as they open new avenues for exploring how fucosylation impacts cell behavior and provides insights into innovative therapeutic strategies aimed at modulating such pathways. Additionally, these tools enhance reproducibility in experimental design and contribute significantly to the body of knowledge in glycoscience.
Our company prides itself on offering high-quality, well-characterized cell lines, backed by a commitment to advancing research in glycosylation and therapeutics. With extensive expertise in genetic engineering, we ensure that our FUT4 Gene Knockout Cell Lines are a reliable and instrumental resource for investigators dedicated to unraveling complex biological questions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.